Eprinomectin

Brand names: Nexgard Combo · Active ingredient: Eprinomectin

In short: NexGard® COMBO is indicated for the prevention of heartworm disease caused by Dirofilaria immitis and for the treatment and control of roundworm (fourth stage larval and adult Toxocara cati), hookworm (fourth stage larval and adult Ancylostoma tubaeforme; adult Ancylostoma braziliense), and tapeworm

LabelBoehringer Ingelheim Animal Health USA Inc.
Label updatedNov 05, 2026

What is Eprinomectin used for?

NexGard® COMBO is indicated for the prevention of heartworm disease caused by Dirofilaria immitis and for the treatment and control of roundworm (fourth stage larval and adult Toxocara cati), hookworm (fourth stage larval and adult Ancylostoma tubaeforme; adult Ancylostoma

braziliense), and tapeworm (Dipylidium caninum) infections. NexGard® COMBO kills adult fleas (Ctenocephalides felis) and is indicated for the treatment and prevention of flea infestations and the treatment and control of Ixodes scapularis (black-legged tick) and Amblyomma americanum (lone star tick) infestations for one month in cats and kittens 8 weeks of age and older, and weighing 1.8 lbs or greater.

⚠ Boxed warning (FDA's strongest warning)

Not for human use. Keep this and all drugs out of sight and reach of children.

Avoid direct contact with application site for 4 hours or until visibly dry.

This product may act as a mild to moderate eye irritant.

Keep product in the original packaging until use. Wash hands after product administration. If the product accidentally gets into the eyes, rinse thoroughly with water. If wearing contact lenses, flush the eyes first with water and then remove the lenses and continue to flush thoroughly with water. In case of accidental ingestion, or if skin or eye irritation occurs, contact a poison control center or physician for treatment advice.

Eprinomectin dosage

NexGard® COMBO is dosed at a minimum of 0.055 mL/lb (0.12 mL/kg), which delivers a minimum dose of 0.65 mg/lb (1.44 mg/kg) esafoxolaner, 0.22 mg/lb (0.48 mg/kg) eprinomectin, and 4.53 mg/lb (9.98 mg/kg) praziquantel.

For heartworm disease prevention, apply once monthly for at least three months after last exposure to mosquitoes .

Administer the entire contents of a NexGard® COMBO unit applicator topically once a month as specified in the following table:

Dosing Schedule

Cat Weight (lb) | Volume (mL) | Esafoxolaner (mg) | Eprinomectin (mg) | Praziquantel (mg)

1.8- 5.5 | 0.3 | 3.6 | 1.2 | 24.9

5.6-16.5 | 0.9 | 10.8 | 3.6 | 74.7

16.6-22 | 0.3 + 0.9 | 14.4 | 4.8 | 99.6

22.1-33 | 0.9 + 0.9 | 21.6 | 7.2 | 149.4

A veterinarian or veterinary technician should demonstrate or instruct the pet owner regarding the appropriate technique for applying NexGard® COMBO topically to cats and kittens prior to first use.

Keep product in original packaging until ready to use.

1.Use scissors to cut the blister along the dotted line.

2.Then pull the lid away.

3.Remove the applicator from the package and hold it upright. Pull back the plunger slightly.

4.Twist and pull off the cap.

5.Part the hair on the midline of the neck, between the base of the skull and the shoulder blades until the skin is visible. Place the tip of the applicator on the skin and apply the entire contents directly onto the skin in one spot. The product should be applied to dry skin on an area where the cat cannot lick it off. If the weight of the cat requires a second application, apply the contents in the same manner as described above in the same location.

6.Wash hands after use with soap and water.

Heartworm Prevention:

For the prevention of heartworm disease, NexGard® COMBO should be administered once a month year-round. At a minimum, administration of NexGard® COMBO should start at least 1 month before the cat’s first expected exposure to mosquitoes and monthly thereafter until at least 3 months after the cat’s last seasonal exposure to mosquitoes . If a dose is missed and a 30-day interval between doses is exceeded, administer NexGard® COMBO immediately and resume the monthly dosing schedule. Treatment with fewer than 3 monthly doses may not provide complete heartworm prevention. When replacing another monthly heartworm preventive product in a heartworm prevention program, the first treatment with NexGard® COMBO should be given within one month of the last dose of the former medication. At the discretion of the veterinarian, cats older than 6 months of age may be tested to determine the presence of existing heartworm infection before treatment with NexGard® COMBO. Cats already infected with adult heartworms can be given NexGard® COMBO monthly to prevent further infections. …

Warnings & precautions

Do not take this medicine if: There are no known contraindications for the use of NexGard® COMBO.

Esafoxolaner, one of the ingredients in NexGard® COMBO, is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders.

Do not administer orally. Cats may salivate excessively if NexGard® COMBO is accidentally administered orally or is ingested through licking/grooming the application site .

The safety of NexGard® COMBO has not been fully evaluated in breeding, pregnant, or lactating cats.

The safety of NexGard® COMBO has not been tested in kittens less than 8 weeks of age or weighing less than 1.8 lbs (0.8 kg).

Eprinomectin side effects

In a field safety and effectiveness study, which included a total of 201 households and 380 treated cats (244 cats treated with NexGard® COMBO, 136 cats treated with an active control), the safety of NexGard® COMBO was evaluated over a 90-day period through in-clinic physical examinations or through reporting of abnormalities by the owner. The most frequently reported reactions in the NexGard® COMBO and active control groups are presented in the following table.

Adverse Reactions by Treatment Group

EVENT | Treatment Group

NexGard® COMBO | Active Control

n1 | % (n=244) | n2 | % (n=136)

Vomiting | 16 | 6.56 | 8 | 5.88

Application Site Hair Change | 9 | 3.69 | 0 | 0.00

Anorexia | 7 | 2.87 | 4 | 2.94

Lethargy | 6 | 2.46 | 5 | 3.68

Bacterial skin infection | 4 | 1.64 | 1 | 0.74

Itching | 4 | 1.64 | 0 | 0.00

Sneezing | 4 | 1.64 | 5 | 3.68

Skin Peeling | 3 | 1.23 | 2 | 1.47

Diarrhea | 3 | 1.23 | 3 | 2.21

Epiphora | 3 | 1.23 | 1 | 0.74

Hypersalivation | 3 | 1.23 | 0 | 0.00

Hyperthermia | 3 | 1.23 | 0 | 0.00

Alopecia | 2 | 0.82 | 0 | 0.00

Dermal thickening | 2 | 0.82 | 0 | 0.00

Ear Pruritus | 2 | 0.82 | 1 | 0.74

Application Site Redness | 2 | 0.82 | 0 | 0.00

Conjunctivitis | 1 | 0.41 | 1 | 0.74

1Number of cats treated with NexGard® COMBO with the identified abnormality.

2Number of cats treated with Active Control with the identified abnormality.

About this medicine

NexGard® COMBO is a topical solution containing esafoxolaner, eprinomectin and praziquantel available in 0.3 mL and 0.9 mL unit applicators to treat cats from 1.8 lbs to 33 lbs. Each mL of NexGard® COMBO contains 12 mg of esafoxolaner, 4 mg of eprinomectin, and 83 mg of praziquantel. Inactive ingredients: dimethyl isosorbide, unstabilized glycerol formal, and butylated hydroxytoluene.

Esafoxolaner is a member of the aryl isoxazoline class of compounds. Its chemical name is 4-[(5S)-5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4, 5-dihydro-1,2-oxazol-3-yl]-N-{2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl}-1-naphthamide.

Eprinomectin belongs to the avermectin class of anthelmintics and is a mixture of homologous components referred to as eprinomectin B1a and B1b. The chemical name for eprinomectin B1a is (4”R)-acetylamino-5-O-demethyl-4”-deoxyavermectin A1a. The chemical name for eprinomectin B1b is (4”R)-acetylamino-5-O-demethyl-25-de(1-methylpropyl)- 4”-deoxy-25-(1-methylethyl)avermectin A1a.

Praziquantel is a pyrazinoisoquinoline anthelmintic. …

Disclaimer: This page is for general information only and is not medical advice. It is a condensed summary of the official FDA-approved label — it does not replace the full prescribing information or the advice of your doctor or pharmacist. Always follow your prescriber's instructions and read the medication guide that comes with your medicine.

Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 48dd3eaa-18e3-430d-ad40-a964b591fb16. Read the full official label on DailyMed.